These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 38260585)
1. Identification of extracellular membrane protein ENPP3 as a major cGAMP hydrolase, cementing cGAMP's role as an immunotransmitter. Mardjuki R; Wang S; Carozza JA; Abhiraman GC; Lyu X; Li L bioRxiv; 2024 Jan; ():. PubMed ID: 38260585 [TBL] [Abstract][Full Text] [Related]
2. Identification of the extracellular membrane protein ENPP3 as a major cGAMP hydrolase and innate immune checkpoint. Mardjuki R; Wang S; Carozza J; Zirak B; Subramanyam V; Abhiraman G; Lyu X; Goodarzi H; Li L Cell Rep; 2024 May; 43(5):114209. PubMed ID: 38749434 [TBL] [Abstract][Full Text] [Related]
3. ENPP1 is an innate immune checkpoint of the anticancer cGAMP-STING pathway. Wang S; Böhnert V; Joseph AJ; Sudaryo V; Swinderman J; Yu FB; Lyu X; Skariah G; Subramanyam V; Gilbert LA; Goodarzi H; Lingyin L bioRxiv; 2023 Jun; ():. PubMed ID: 37333273 [TBL] [Abstract][Full Text] [Related]
4. ENPP1 is an innate immune checkpoint of the anticancer cGAMP-STING pathway in breast cancer. Wang S; Böhnert V; Joseph AJ; Sudaryo V; Skariah G; Swinderman JT; Yu FB; Subramanyam V; Wolf DM; Lyu X; Gilbert LA; Van't Veer LJ; Goodarzi H; Li L Proc Natl Acad Sci U S A; 2023 Dec; 120(52):e2313693120. PubMed ID: 38117852 [TBL] [Abstract][Full Text] [Related]
5. Extracellular cGAMP is a cancer cell-produced immunotransmitter involved in radiation-induced anti-cancer immunity. Carozza JA; Böhnert V; Nguyen KC; Skariah G; Shaw KE; Brown JA; Rafat M; von Eyben R; Graves EE; Glenn JS; Smith M; Li L Nat Cancer; 2020 Feb; 1(2):184-196. PubMed ID: 33768207 [TBL] [Abstract][Full Text] [Related]
6. ENPP1's regulation of extracellular cGAMP is a ubiquitous mechanism of attenuating STING signaling. Carozza JA; Cordova AF; Brown JA; AlSaif Y; Böhnert V; Cao X; Mardjuki RE; Skariah G; Fernandez D; Li L Proc Natl Acad Sci U S A; 2022 May; 119(21):e2119189119. PubMed ID: 35588451 [TBL] [Abstract][Full Text] [Related]
7. Stimulating STING for cancer therapy: Taking the extracellular route. Li L Cell Chem Biol; 2024 May; 31(5):851-861. PubMed ID: 38723635 [TBL] [Abstract][Full Text] [Related]
8. Biochemistry, Cell Biology, and Pathophysiology of the Innate Immune cGAS-cGAMP-STING Pathway. Ritchie C; Carozza JA; Li L Annu Rev Biochem; 2022 Jun; 91():599-628. PubMed ID: 35287475 [TBL] [Abstract][Full Text] [Related]
9. SLC19A1 Is an Importer of the Immunotransmitter cGAMP. Ritchie C; Cordova AF; Hess GT; Bassik MC; Li L Mol Cell; 2019 Jul; 75(2):372-381.e5. PubMed ID: 31126740 [TBL] [Abstract][Full Text] [Related]
10. Structure-Aided Development of Small-Molecule Inhibitors of ENPP1, the Extracellular Phosphodiesterase of the Immunotransmitter cGAMP. Carozza JA; Brown JA; Böhnert V; Fernandez D; AlSaif Y; Mardjuki RE; Smith M; Li L Cell Chem Biol; 2020 Nov; 27(11):1347-1358.e5. PubMed ID: 32726585 [TBL] [Abstract][Full Text] [Related]
11. Metastasis and Immune Evasion from Extracellular cGAMP Hydrolysis. Li J; Duran MA; Dhanota N; Chatila WK; Bettigole SE; Kwon J; Sriram RK; Humphries MP; Salto-Tellez M; James JA; Hanna MG; Melms JC; Vallabhaneni S; Litchfield K; Usaite I; Biswas D; Bareja R; Li HW; Martin ML; Dorsaint P; Cavallo JA; Li P; Pauli C; Gottesdiener L; DiPardo BJ; Hollmann TJ; Merghoub T; Wen HY; Reis-Filho JS; Riaz N; Su SM; Kalbasi A; Vasan N; Powell SN; Wolchok JD; Elemento O; Swanton C; Shoushtari AN; Parkes EE; Izar B; Bakhoum SF Cancer Discov; 2021 May; 11(5):1212-1227. PubMed ID: 33372007 [TBL] [Abstract][Full Text] [Related]
12. Second messenger 2'3'-cyclic GMP-AMP (2'3'-cGAMP): the cell autonomous and non-autonomous roles in cancer progression. Ma XY; Chen MM; Meng LH Acta Pharmacol Sin; 2024 May; 45(5):890-899. PubMed ID: 38177693 [TBL] [Abstract][Full Text] [Related]
13. Discovery of Imidazo[1,2- Zhan S; Zhang Y; Cao T; Yang R; Wang Q; Huang L; Cui R; Yu J; Meng H; Wang Y; Zhang S; Zheng M; Wu X J Med Chem; 2024 Oct; 67(20):18317-18333. PubMed ID: 39357030 [TBL] [Abstract][Full Text] [Related]
14. Hydrolysis of 2'3'-cGAMP by ENPP1 and design of nonhydrolyzable analogs. Li L; Yin Q; Kuss P; Maliga Z; Millán JL; Wu H; Mitchison TJ Nat Chem Biol; 2014 Dec; 10(12):1043-8. PubMed ID: 25344812 [TBL] [Abstract][Full Text] [Related]
15. Development of cGAMP-Luc, a sensitive and precise coupled enzyme assay to measure cGAMP in complex biological samples. Mardjuki RE; Carozza JA; Li L J Biol Chem; 2020 Apr; 295(15):4881-4892. PubMed ID: 32127400 [TBL] [Abstract][Full Text] [Related]
16. Targeting ENPP1 for cancer immunotherapy: Killing two birds with one stone. Huang R; Ning Q; Zhao J; Zhao X; Zeng L; Yi Y; Tang S Biochem Pharmacol; 2024 Feb; 220():116006. PubMed ID: 38142838 [TBL] [Abstract][Full Text] [Related]
17. An alternatively spliced STING isoform localizes in the cytoplasmic membrane and directly senses extracellular cGAMP. Li X; Zhu Y; Zhang X; An X; Weng M; Shi J; Wang S; Liu C; Luo S; Zheng T J Clin Invest; 2022 Feb; 132(3):. PubMed ID: 34905508 [TBL] [Abstract][Full Text] [Related]
18. Second messenger 2'3'-cyclic GMP-AMP (2'3'-cGAMP): Synthesis, transmission, and degradation. Su M; Zheng J; Gan L; Zhao Y; Fu Y; Chen Q Biochem Pharmacol; 2022 Apr; 198():114934. PubMed ID: 35104477 [TBL] [Abstract][Full Text] [Related]
19. Discovery of orally bioavailable phosphonate prodrugs of potent ENPP1 inhibitors for cancer treatment. Gao S; Hou Y; Xu Y; Li J; Zhang C; Jiang S; Yu S; Liu L; Tu W; Yu B; Zhang Y; Li L Eur J Med Chem; 2024 Dec; 279():116853. PubMed ID: 39270452 [TBL] [Abstract][Full Text] [Related]
20. T Cell-Derived Apoptotic Extracellular Vesicles Hydrolyze cGAMP to Alleviate Radiation Enteritis via Surface Enzyme ENPP1. Zhou Y; Bao L; Gong S; Dou G; Li Z; Wang Z; Yu L; Ding F; Liu H; Li X; Liu S; Yang X; Liu S Adv Sci (Weinh); 2024 Aug; 11(31):e2401634. PubMed ID: 38888507 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]